Diagnostics AI
By
Is NVIDIA Powering the AI Revolution in Medical Diagnostics as Healthcare Partners Commit to Next‑Gen Intelligence Platforms?
Executive Summary NVIDIA, the global leader in accelerated computing and AI infrastructure, is increasingly at the core of…
Can AI-Automated Hematology Redefine Laboratory Diagnostics? WORK Medical Secures Manufacturing Approval for Class II Blood Cell Analyzer
Hangzhou, China – December 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) today announced that its subsidiary,…
FDA Qualifies First AI Drug Development Tool, Will Be Used in ‘MASH’ Clinical Trials to Accelerate Liver Disease Drug Development
The U.S. Food and Drug Administration (FDA) has qualified AIM-NASH, the first AI-based tool designed to assist doctors…
Can Labcorp’s AI-Powered Test Finder Redefine Diagnostic Efficiency for 750+ Health Systems Nationwide?
Key Highlights Expansion Into Clinical WorkflowsLabcorp (NYSE: LH) announced the integration of its AI-driven Test Finder into Labcorp…
Is Arterys Leading Cloud-Native AI in Medical Imaging as Health Systems Scale Diagnostic Intelligence and Care Performance?
Executive Summary Arterys, a pioneer in cloud-native medical imaging AI, is shaping the future of diagnostic workflows by…
Can Zebra Medical Vision (Zebra-AI) Drive Widespread Clinical AI Adoption by Delivering End-to-End Imaging Analytics and Operational Value to Global Healthcare Systems?
Overview: Healthcare Intelligence Beyond Diagnostic Alerts Zebra Medical Vision (Zebra-AI) is emerging as a differentiated leader in AI-driven…
